Bicycle Net Interest Income from 2010 to 2026
| BCYC Stock | USD 6.00 0.49 7.55% |
Net Interest Income | First Reported 2019-03-31 | Previous Quarter 7.4 M | Current Value 6.7 M | Quarterly Volatility 3.6 M |
Check Bicycle Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bicycle Therapeutics' main balance sheet or income statement drivers, such as Interest Income of 41.4 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 8.7 M, as well as many indicators such as Price To Sales Ratio of 52.04, Dividend Yield of 0.0 or PTB Ratio of 1.12. Bicycle financial statements analysis is a perfect complement when working with Bicycle Therapeutics Valuation or Volatility modules.
Bicycle | Net Interest Income | Build AI portfolio with Bicycle Stock |
Analyzing Bicycle Therapeutics's Net Interest Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Interest Income has evolved provides context for assessing Bicycle Therapeutics's current valuation and future prospects.
Latest Bicycle Therapeutics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Bicycle Therapeutics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Bicycle Therapeutics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bicycle Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Bicycle Net Interest Income Regression Statistics
| Arithmetic Mean | 7,129,180 | |
| Coefficient Of Variation | 200.61 | |
| Mean Deviation | 10,767,334 | |
| Median | 50,000 | |
| Standard Deviation | 14,301,603 | |
| Sample Variance | 204.5T | |
| Range | 42.2M | |
| R-Value | 0.71 | |
| Mean Square Error | 106.7T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 2,024,687 | |
| Total Sum of Squares | 3272.6T |
Bicycle Net Interest Income History
About Bicycle Therapeutics Financial Statements
Bicycle Therapeutics stakeholders use historical fundamental indicators, such as Bicycle Therapeutics' Net Interest Income, to determine how well the company is positioned to perform in the future. Although Bicycle Therapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bicycle Therapeutics' assets and liabilities are reflected in the revenues and expenses on Bicycle Therapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bicycle Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 37.4 M | 39.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bicycle Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bicycle Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bicycle Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bicycle Therapeutics Stock:Check out the analysis of Bicycle Therapeutics Correlation against competitors. For information on how to trade Bicycle Stock refer to our How to Trade Bicycle Stock guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Will Biotechnology sector continue expanding? Could Bicycle diversify its offerings? Factors like these will boost the valuation of Bicycle Therapeutics. Projected growth potential of Bicycle fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Bicycle Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (3.62) | Revenue Per Share | Quarterly Revenue Growth 3.385 | Return On Assets | Return On Equity |
The market value of Bicycle Therapeutics is measured differently than its book value, which is the value of Bicycle that is recorded on the company's balance sheet. Investors also form their own opinion of Bicycle Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Bicycle Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Bicycle Therapeutics' market value can be influenced by many factors that don't directly affect Bicycle Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Bicycle Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bicycle Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Bicycle Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.